ArticleThe Journal of experimental medicine2024

MCRS1 sensitizes T cell-dependent immunotherapy by augmenting MHC-I expression in solid tumors.

Xue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.